Electronic self-report assessment for cancer (ESRA-C): Results of a randomized clinical trial

Berry, Donna L.; Halpenny, Barbara; Fann, Jean Ching Yuan; Bush, Nancy Ann Oberheim; Lober, William B.; Wolpin, Seth; Karras, Bryant T.; Austin-Seymour, M.; McCorkle, Ruth

doi:10.1200/jco.2008.26.15_suppl.9519

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the ESRA-C summary report for providers is known to increase the frequency with which cancer symptoms and quality-of-life concerns are discussed during on-treatment visits in ambulatory cancer care centers (Berry et al, 2008), this analysis extends the authors' understanding of the conversations that occur relevant to socioemotional cues.…”

Section: Discussionmentioning

confidence: 95%

Provider Verbal Responses to Patient Distress Cues During Ambulatory Oncology Visits

Sheldon¹,

Hilaire²,

Berry³

2011

Oncology Nursing Forum

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 95%

Provider Verbal Responses to Patient Distress Cues During Ambulatory Oncology Visits

Sheldon¹,

Hilaire²,

Berry³

2011

Oncology Nursing Forum

View full text Add to dashboard Cite

show abstract

“…The reported acceptability of this tailored decision aid is comparable to that of other electronic, Web-based applications developed by this research team and colleagues. The electronic self-report assessment for cancer (ESRA-C) is a screening assessment for patients with all cancer diagnoses shown to be efficacious for improving clinician patient communication [ 31 ]. Wolpin et al [ 32 ] reported similarly high levels of acceptability for the ESRA-C application including 342 ambulatory patients with cancer who had completed the program at 2 time points.…”

Section: Discussionmentioning

confidence: 99%

Development and Evaluation of the Personal Patient Profile-Prostate (P3P), a Web-Based Decision Support System for Men Newly Diagnosed With Localized Prostate Cancer

et al. 2010

View full text Add to dashboard Cite

Background Given that no other disease with the high incidence of localized prostate cancer (LPC) has so many treatments with so few certainties related to outcomes, many men are faced with assuming some responsibility for the treatment decision along with guidance from clinicians. Men strongly consider their own personal characteristics and other personal factors as important and influential to the decision. Clinical researchers have not developed or comprehensively investigated interventions to facilitate the insight and prioritizing of personal factors along with medical factors that are required of a man in preparation for the treatment decision.Objectives The purpose of this pilot study was to develop and evaluate the feasibility and usability of a Web-based decision support technology, the Personal Patient Profile-Prostate (P3P), in men newly diagnosed with LPC.Methods Use cases were developed followed by infrastructure and content application. The program was provided on a personal desktop computer with a touch screen monitor. Participant responses to the query component of P3P determined the content of the multimedia educational and coaching intervention. The intervention was tailored to race, age, and personal factors reported as influencing the decision. Prepilot usability testing was conducted using a “think aloud” interview to identify navigation and content challenges. These issues were addressed prior to deployment in the clinic. A clinical pilot was conducted in an academic medical center where men sought consultation and treatment for LPC. Completion time, missing data, and acceptability were measured.Results Prepilot testing included 4 men with a past diagnosis of LPC who had completed therapy. Technical navigation issues were documented along with confusing content language. A total of 30 additional men with a recent diagnosis of LPC completed the P3P program in clinic prior to consulting with a urologist regarding treatment options. In a mean time of 46 minutes (SD 13 minutes), participants completed the P3P query and intervention components. Of a possible 4560 items for 30 participants, 22 (0.5%) were missing. Acceptability was reported as high overall. The sections of the intervention reported as most useful were the statistics graphs, priority information topics, and annotated external website links.Conclusions The P3P intervention is a feasible and usable program to facilitate treatment decision making by men with newly diagnosed LPC. Testing in a multisite randomized trial with a diverse sample is warranted.

show abstract

Patient cues and symptoms of psychosocial distress: what predicts assessment and treatment of distress by oncology clinicians?

et al. 2014

View full text Add to dashboard Cite

show abstract

Electronic self-report assessment for cancer (ESRA-C): Results of a randomized clinical trial

Cited by 3 publications

References 0 publications

Provider Verbal Responses to Patient Distress Cues During Ambulatory Oncology Visits

Provider Verbal Responses to Patient Distress Cues During Ambulatory Oncology Visits

Development and Evaluation of the Personal Patient Profile-Prostate (P3P), a Web-Based Decision Support System for Men Newly Diagnosed With Localized Prostate Cancer

Patient cues and symptoms of psychosocial distress: what predicts assessment and treatment of distress by oncology clinicians?

Contact Info

Product

Resources

About